Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 224,453 shares, a growth of 90.8% from the July 15th total of 117,659 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 613,487 shares, the short-interest ratio is currently 0.4 days.
Analyst Ratings Changes
Separately, Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Coloplast A/S has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on CLPBY
Coloplast A/S Stock Down 0.4%
Coloplast A/S Company Profile
Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.
In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.
Further Reading
- Five stocks we like better than Coloplast A/S
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
